Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection-Reference-Cited by-同舟云学术

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

Published:2014-12-23 Issue:1 Volume:30 Page:184-191
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Colvin Richard A¹,Tanwandee Tawesak²,Piratvisuth Teerha³,Thongsawat Satawat⁴,Hui Aric Josun⁵,Zhang Hongfei⁶,Ren Hong⁷,Chen Pei-Jer⁸,Chuang Wan-Long⁹,Sobhonslidsuk Abhasnee¹⁰,Li Ruobing¹¹,Qi Yin¹¹,Praestgaard Jens¹²,Han Yi¹³,Xu Junfang¹³,Stein Daniel S¹²,

Affiliation:

1. Novartis Institutes for BioMedical Research; Cambridge Massachusetts USA

2. Siriraj Hospital; Mahidol University; Bangkok Thailand

3. Prince of Songkhla University; Hat Yai Songkla Thailand

4. Maharaj Nakorn Chiang Mai Hospital; Chiang Mai University; Chiang Mai Thailand

5. Alice Ho Miu Ling Nethersole Hospital; The Chinese University of Hong Kong; Hong Kong

6. Military Hospital of China; Beijing China

7. Chongqing Medical University 2nd Affiliated Hospital; Chongqing China

8. National Taiwan University Hospital; Taipei City Taiwan

9. Kaohsiung Medical University Chung-Ho Memorial Hospital; Kaohsiung Taiwan

10. Ramathibodi Hospital; Mahidol University; Bangkok Thailand

11. China Novartis Institutes for BioMedical Research Co; Beijing China